New application note with AIM Biotech and Nikon: Confocal Imaging of in vitro BBB model using idenTx platform

AIM Biotech and Nikon Instruments have produced a new application note demonstrating a robust and cost-effective way to assess neurotherapeutic drug transport and neurovascular function of the human blood brain barrier (BBB) in vitro. The human cell tri-culture BBB model results in a self-organized microvascular network, while both confocal and widefield microscopy enable identification of cell/BBB-specific markers and microvascular permeability, respectively. Click below to see the full application note.

You can also find this and our other application notes at Want to discuss how idenTx can transform your drug discovery research? Use the chat bubble on the bottom right corner of this page, and we’ll reach out to you—or check out our Contact Us page. Also be sure to look at how our contract research services can help streamline your workflow.